Autosomal Dominant Polycystic Kidney Disease, caused by mutations in the PKD1 gene, is characterized by progressive deterioration of kidney function due to the formation of thousands of cysts leading to kidney failure in mid-life or later. How cysts develop and grow is currently unknown, although extensive research revealed a plethora of cellular changes in cyst lining cells. We have constructed a tamoxifen-inducible, kidney epitheliumspecific Pkd1-deletion mouse model. Upon administration of tamoxifen to these mice, a genomic fragment containing exons 2-11 of the Pkd1-gene is specifically deleted in the kidneys and cysts are being formed.
INTRODUCTION
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a common genetic disease characterized by progressive development of fluid-filled cysts in both kidneys. The formation of numerous cysts together with interstitial fibrosis usually causes chronic renal failure in 50% of patients by the age of 60 years (1) . The kidney is the most severely affected organ, but the disease is systemic and extra-renal manifestations such as cyst formation in liver and pancreas, hypertension, and cerebral aneurysms also can occur (2) .
The majority of patients, 85%, carry a mutation in the PKD1 gene (3) . The protein encoded by the PKD1 gene, polycystin 1, forms multiprotein complexes at the cell membrane and functions in cell-cell and cell-matrix interactions, signal transduction and in mechanosensation (4) . The C-terminal region of polycystin-1 has been shown to interact with the PKD2 gene product, polycystin-2, which is mutated in approximately 15% of the ADPKD patients, and functions as a Ca 2+ -permeable cation channel (5-7). Both polycystins have been found in primary cilia. Several proteins in this cell organelle have been reported to be associated with cystic diseases and are probably participating in sensing fluid flow or shear stress (8) .
ADPKD patients carry one germ-line mutation and one normal PKD1 allele. Two genetic mechanisms for cyst formation have been postulated, e.g. somatic inactivation of PKD1 or PKD2 by a 'two-hit' mechanism has been shown for cysts in PKD1 and PKD2 kidneys (9,10) but reduced levels of polycystins may already be sufficient to cause polycystic kidney disease (11, 12) . In addition, cysts formation in mice over expressing Pkd1 suggest that a balanced polycystin-1 and -2 dosage seem critical to maintain an intact renal epithelial architecture (13, 14) .
A plethora of cellular changes in cyst-lining cells have been observed, but the precise mechanisms how cysts arise and grow are still not well understood. To study the pathogenesis of ADPKD several mouse models have now been generated. Homozygous Pkd1 and Pkd2 knock-out mice die at embryonic stages, around E15.5, or directly after birth due to severe cystic disease, vascular defects and/or abnormalities of the placental labyrinth (15) (16) (17) (18) (19) (20) . Heterozygous knock-out mice showed minimal renal cyst
RESULTS

Generation of inducible and kidney-specific Pkd1 mutant mice
To get more insight in cyst formation and cyst progression, we created a conditional and inducible As expected, tamoxifen administration resulted in formation of the deleted allele, as shown by allele-specific PCR on genomic DNA isolated from the kidneys (Fig. 2) .
Inactivation of the Pkd1 gene in kidneys causes cyst formation
When we treated transgenic Cre;Pkd1 del2-11,lox mice at 3 to 6 month of age with tamoxifen, pathologic examination of these mice revealed a mild cystic phenotype in the kidneys. At one month upon tamoxifen administration dilated tubules and 1-5 microscopic cyst per cross section could be detected (n=4) and after 3 months, approximately 10 microscopic renal cysts per cross section and occasionally a small macroscopic cyst (cyst area 0.8 mm 2 ) could be seen (n=4) (Fig. 3A) . Cysts were detected bilaterally, in the cortex and the medulla.
In contrast, when four days old mice (PN4) received tamoxifen via breast feeding by the weaning mother, massive cyst formation was observed when sacrificed 1 month later (n=9, Fig. 3B ). In these mice after 13 days small cysts can sometimes be observed (n=15) (Fig. 3C ). The majority of cysts arise from distal parts of the nephron and are uromodulin-positive (Fig. 3D ). Dilated collecting ducts were also frequently observed. Transgenic mice with two floxed Pkd1 alleles (n=3), showed a slightly milder cystic phenotype compared to Cre;Pkd1 del2-11,lox littermates (n=3) (Fig. 3E) . No liver or pancreatic cysts were detected in the young conditional knock-out mice. Adult tamoxifen-treated Cre;Pkd1 del2-11,lox animals also showed no pancreatic cysts but in the liver 0-5 microscopic and occasionally a macroscopic cyst per cross section could be observed, similar as in wt;Pkd1 del2-11,+ and wt;Pkd1 del2-11,lox mice of 4-11 months. These findings support previous data that deletion of the floxed Pkd1 gene mediated by our KspCad-CreER T2 mouse line is restricted to the kidneys (24) .
Prolonged follow-up of adult-induced mice revealed that in time these animals do develop more severe PKD. Mice sacrificed at 5 months after tamoxifen-administration showed kidneys that were paler and were more or less enlarged compared to controls. Four out of 5 mice had kidney/body weight ratios above 2%, up to 9.5% (Controls 1.3-1.8%, n=5). Male mice tend to manifest a more severe cystic phenotype while the recombination efficiency was similar in female and male animals. Histological examination revealed many dilated tubules and microcysts, especially at the medullar-cortical boundaries (Fig. 3F) . Staining with kidney-segment markers showed that dilated tubules originated from all nephronsegments and collecting ducts and that many cysts showed no staining.
Maternal administration of tamoxifen induces a progressive cystic phenotype in newborn mutant
mice but a slow disease onset in the mutant mothers
In the experiments described above, adult mice had received tamoxifen via a feeding needle, while young mice received tamoxifen via the milk from the mother who was treated. In most of these experiments the mother herself did not have the triple mutant phenotype. To minimize, however, the possibility that a technical artifact was underlying the phenotypic differences observed between adult and young mice, we treated three Cre;Pkd1 del2-11,lox mothers with tamoxifen and carefully analyzed the pathology in mothers and progeny. In agreement with the phenotypes found in unrelated young and adult mice, the Cre;Pkd1 del2-11,lox progeny sacrificed after 1 month showed a much more severe polycystic phenotype than their mothers sacrificed after 1 to 5 months (Fig. 3G,H) .
Efficient Cre-mediated deletion of the floxed Pkd1 allele
To ascertain that recombination of the floxed allele had occurred in tamoxifen-treated triple transgenic mice, we performed a quantitative PCR on genomic DNA, isolated from the kidneys.
Essentially, we analyzed the increase in deletion allele using primers in intron 1 and intron 11, flanking the deletion. In addition kidneys of tamoxifen-treated Cre;Pkd1 lox,+ mice were analyzed as well. Since 
Cell proliferation differs in newborn and adult mice
We hypothesized that the proliferation status of the tissue may underlie the observed pathogenic differences between the adult and newborn tamoxifen-treated triple mice. Therefore, we stained kidney sections with the proliferation marker Ki-67. A substantial number of proliferating cells can be observed in newborn wild-type mice, while in adult wild-type controls Ki-67 positive nuclei can hardly be found, indicating that at the moment of tamoxifen treatment the renal epithelium is proliferative in young mice but scarcely in adults (Fig 5) . The mean proliferation index (PI) in kidneys of young mice (postnatal week 1) was 8.2% (range 4.4-16%, n=4) while in adult mice (>3 months) the mean proliferation index was around 0.2% (range 0.1-0.4, n=3) (Table 1A) .
Pkd1 haploinsufficiency is associated with increased renal epithelial cell proliferation
In cystic kidneys, the epithelia of dilated tubules and small cysts show strong proliferation, as many nuclei are Ki-67 positive. Large cysts incidentally show a positive nucleus (Fig. 5 ). An association between haploinsuffiency of Pkd genes and an increased proliferating index has been postulated for renal tissues of ADPKD patients and adult heterozygous Pkd2 mice compared to controls (25) . To address this issue in our mouse models we measured the proliferation index (PI) of precystic tubular epithelial cells in different Pkd1 mutant mice and controls. Adult mice that carry only one Pkd1 allele show a higher PI compared to mice that carry no deletion allele (mean 1.2% vs. mean 0.3%, p<0.01), suggesting that a germ-line mutation of Pkd1 results in increased proliferation (Table 1B) . The adult conditional knock-out mice show roughly a five to twenty fold increase in Ki-67 index compared to mice that carry no deletion allele. These mice were sacrificed at 3 or 5 months after tamoxifen-treatment and displayed variable cystic phenotypes. In the group of mice sacrificed three months after treatment, which show grossly normal tubules, the PI was not significantly different from mice with one deletion allele (compare mean PI 1.9 %, n=5, to mean 1.2%, n=8; p=0.14). In the mice sacrificed 5 months after treatment, which show many dilated tubules, a significant increase in Ki-67 index was observed (mean PI 5.2%, n=5; p= 0.02).
In the young-age-treated mice the increase in proliferation index upon Pkd1 disruption, was not significant (Table 1B) , either because there is not yet an increased PI or because base line proliferation of renal cells in young mice is too high to demonstrate any additional increase. All together these data support the idea that deletion of Pkd1 results in increased renal epithelial proliferation with conditional knock-outs displaying cystic changes showing the highest levels of proliferation.
DISCUSSION
In this paper we present the first study describing an inducible and kidney-specific Pkd1 knockout mouse model to study ADPKD. Our findings show that timing of Pkd1 gene disruption has a major effect on the severity of cyst development. Adult mice showed a mild cystic phenotype one month after the tamoxifen-treatment that resulted in disruption of the Pkd1 gene in a substantial number of cells.
Newborn mice, in contrast, and in spite of a lower percentage of Pkd1 deletion, showed rapid and massive cyst formation in the same time-frame, suggesting that in these mice renal tissue is highly susceptible to cystogenesis, while in adult mice, with a relatively mild phenotype, it is not. We hypothesized that the proliferation status of the tissue may underlie the observed pathogenic differences in adult and young mice. Indeed, staining with the proliferation marker Ki-67 showed a substantial number of proliferating cells in newborn wild-type mice, while in adult wild-type controls Ki-67 positive nuclei can hardly be found, indicating that at the moment of Pkd1 gene inactivation by tamoxifen treatment the renal epithelium is proliferative in young mice but not in adults. Cell proliferation is not only critical for the initiation of cyst formation but proliferation, in addition to extra cellular matrix remodeling and fluid accumulation, is contributing to cyst growth as well.
Indeed the epithelia of dilated tubules and small cysts show increased proliferation, as many nuclei are Ki-67 positive. Large cysts, however, scarcely show positive nuclei, as described for renal cystic tissues from humans and the Han:SPRD-rats. Our data support the notion that proliferation is important in the early steps of cyst formation and cyst growth while at later stages epithelial stretch induced by increased luminal pressure may contribute to cyst growth (32, 33) . Promising results obtained by treatment of two non-orthologues murine models for polycystic kidney disease with the cyclin-dependent kinase inhibitor Roscovitine, also suggest that proliferation may be an important target for therapeutic interventions in ADPKD-patients (34) . Likely, the drug will be more effective in not too advanced stages of the disease.
These non-orthologous mouse and rat models have proven to be very useful to study the pathogenesis of polycystic kidney disease and to test potential therapeutic interventions. Diets or drugs that have been tested, however, sometimes had opposing effects, emphasizing the importance of using models that mimic the human disease (35-38).
Aberrant functioning of primary cilia may also be a The cystic phenotype in adult conditional knock-out mice is in line with the observation that heterozygous Pkd1 +,-mice hardly develop cysts in contrast to ADPKD patients. In this respect, it may be good to realize that mice have a shorter life span, are kept in a highly controlled environment and are not exposed to putative harmful factors like infections, or toxic agents. The kidney has the capacity to regenerate upon renal ischemia, inflammation and drug or toxicant exposure. Renal injury followed by repair processes including proliferation and apoptosis, may be an important permissive condition for cystogenesis in adult mice and in patients.
In conclusion, we have generated the first inducible renal-specific knock-out mouse model for cystogenesis in ADPKD. We can selectively inactivate the Pkd1 gene in renal epithelium in an allelespecific fashion, bypassing the embryonic or postnatal lethality observed in Pkd1-deficient mice.
Conditional knock-out mice do not show extra-renal manifestations like cysts in liver and pancreas and vascular defects as did Pkd1 -/-embryos and 4-week-old Pkd1 hypomorphic mice (11, 15, 16) . Not Therefore, we hypothesize that proliferation in the absence of functional polycystins is a trigger for cyst formation.
MATERIALS AND METHODS
Generation of tam-KspCad-Cre;Pkd1 del2-11,lox mice and tamoxifen administration.
Mice with the Pkd1 del2-11 and Pkd1 lox allele were generated as described for the hypomorphic Pkd1 nl allele (11) . In short, a loxP-flanked PGK-neo-poly(A) cassette in antisense orientation was inserted into the Eco105I site in intron 1 and a synthetic double-stranded oligonucleotide containing a loxP site was cloned into the BglII site in intron 11. The linearized targeting construct was electroporated into 129/Ola embryonic stem (ES) cells, and homologous recombination was identified using 5'-and 3'-external probes. Chimeric mice were obtained by injection of Pkd1 nl,+ ES cells into C57BL/6 blastocysts and clone #4 and #18 were found to transmit the mutant Pkd1 allele through the germ line. Partial or complete excision of the loxP-flanked DNA sequences occurred by crossbreeding clone #18-derived mice with EIIaCre-mice (43) , and the generated mice with the Pkd1 nl , the Pkd1 lox , and the Pkd1 del2-11 alleles were further breed (Fig. 1) . Mice bred on a C57BL/6 background for >8 generations were analyzed in this study. Genotypes were assessed by PCR analysis of tail genomic DNA using a reverse primer in intron 11
combined with a forward primer in intron 1 (del allele) or a forward primer in intron 11 (floxed and wildtype alleles).
Generation of tam-KspCad-CreER T2 mice and tamoxifen treatment have been described previously (24) . Adult mice, 3-4 months of age, have been treated with 5 mg tamoxifen for 3 consecutive days, using a feeding needle. Weaning mothers, 3-6-months-old, received a similar treatment starting at postnatal day 4 (PN4) of the progeny, and these newborn mice received tamoxifen via breast-feeding from the mother.
All experiments using mice were approved by the local animal experimental committee of the Leiden University Medical Center and by the Commission Biotechnology in Animals of the Dutch Ministry of Agriculture.
Quantitative PCR to detect deletions and Cre expression
To quantify the deletion a real-time PCR was performed on genomic DNA isolated from the kidneys of tamoxifen-treated and control mice. The increase in 'deletion' was analyzed as described previously (23) . Essentially, primers have been selected in intron 1 and intron 11, flanking the deletion. As reference PCR, a fragment from exon 36 of the undeleted distal part of the Pkd1 gene was used. DNA isolated from heterozygous Pkd1 del2-11,lox mice (n=6), with 50% of Pkd1 alleles containing a deletion, served as a 50% reference. All measurements were performed three times in triplicate.
RT-PCR measurements to quantify the Cre expression in PN5 (n=6) and adult mice (n=6) were expressed as mean ± SD, related to the median value of adult mice (set at 1.0). Measurements were done in triplicate and performed twice.
Histological analysis
Tissues were fixed in 10% buffered formalin, embedded in paraffin, sectioned at 4 or 5 μm and stained with haematoxylin-eosin (HE). Kidney-segment identity was characterized using lectin Dolichos biflorus, and antisera against uromodulin, aquaporin-2 and megalin as described (11) . Ki-67 (1:3000, Novocastra) staining was performed using standard protocol.
Proliferative index (PI)
The PI was assessed essentially as described by Chang et al. 
Statistical analysis
Statistical comparisons between groups were performed with the Mann-Whitney rank-sum test, at 95% confidence interval. A P-value of <0.05 was considered statistically significant. Agarose gel analysis of PCR products amplified from genomic DNA isolated from kidneys of adult 
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